U.S. Markets closed

Avicanna Inc. (AVCN.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.7200-0.0100 (-1.37%)
At close: 3:59PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7300
Bid0.7200 x N/A
Ask0.7300 x N/A
Day's Range0.7200 - 0.7300
52 Week Range0.6200 - 1.6500
Avg. Volume24,546
Market Cap28.945M
Beta (5Y Monthly)2.17
PE Ratio (TTM)N/A
EPS (TTM)-0.9350
Earnings DateNov 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    MediPharm Labs Completes Medical Cannabis Export to Barbados

    Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities.This marks the fourth new country entered by MediPharm Labs in 2021, following initial shipments to Germany, Brazil and Peru. BARRIE, Ontario, Nov. 26, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a

  • GlobeNewswire

    Avicanna Expands its Medical Cannabis Brand RHO Phyto into the Caribbean Region with Initial Export to Barbados

    RHO Phyto Avicanna Expands its Medical Cannabis Brand RHO Phyto into the Caribbean Region Starting with 3 SKUs, the advanced medical cannabis formulary will be available for the medical community and patients through prescriptionDistribution partnership with Bryden Stokes Limited includes initial focus on Barbados with plans to expand further into the Caribbean regionThird active country for RHO Phyto formulations and 13th international market opening for Avicanna’s products TORONTO, Nov. 25, 20

  • GlobeNewswire

    Avicanna Announces Filing of Interim Financial Statements for the Three-Month Period Ending September 30, 2021, Demonstrating Progressive Commercialization Results

    Record gross revenue of $1,007,033 through steady growth and progression of global commercializationDelivered a record number (27,041) of units of cannabis 2.0 products globally, an increase of 61% from Q225 listings of cannabis 2.0 products across adult use and medical channels in Canada.Expanded into and completed exports into the 12th international market. /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRI